Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Long-Term Investments (2016 - 2025)

Bio-Techne has reported Long-Term Investments over the past 13 years, most recently at $235.0 million for Q4 2025.

  • Quarterly results put Long-Term Investments at $235.0 million for Q4 2025, up 1466.91% from a year ago — trailing twelve months through Dec 2025 was $235.0 million (up 1466.91% YoY), and the annual figure for FY2025 was $236.0 million, down 2.62%.
  • Long-Term Investments for Q4 2025 was $235.0 million at Bio-Techne, roughly flat from $234.9 million in the prior quarter.
  • Over the last five years, Long-Term Investments for TECH hit a ceiling of $257.0 million in Q1 2023 and a floor of $15.0 million in Q3 2024.
  • Median Long-Term Investments over the past 4 years was $235.0 million (2025), compared with a mean of $155.4 million.
  • Biggest five-year swings in Long-Term Investments: crashed 94.04% in 2024 and later skyrocketed 1466.91% in 2025.
  • Bio-Techne's Long-Term Investments stood at $25.0 million in 2022, then surged by 898.92% to $249.7 million in 2023, then crashed by 93.99% to $15.0 million in 2024, then skyrocketed by 1466.91% to $235.0 million in 2025.
  • The last three reported values for Long-Term Investments were $235.0 million (Q4 2025), $234.9 million (Q3 2025), and $236.0 million (Q2 2025) per Business Quant data.